Zobrazeno 1 - 10 of 4 981 pro vyhledávání: '"Chalon, S."'
1
Akademický článek
DESI-TQ-MS imaging for ex vivo brain biodistribution assessment: evaluation of LBT-999, a ligand of the dopamine transporter (DAT).
Autor: Galineau L; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Claude E; Waters Corporation, Stamford Rd, Wilmslow, SK9 4AX, UK., Gulhan Z; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Bodard S; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Sérrière S; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Dupuy C; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Monteiro J; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Oury A; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Bertevello P; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Chicheri G; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Vercouillie J; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Nadal-Desbarats L; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Chalon S; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France., Lefèvre A; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France., Emond P; Université de Tours, INSERM, Imaging Brain & Neuropsychiatry iBraiN U1253, 37032, Tours, France. emond@univ-tours.fr.; Service de Médecine Nucléaire In Vitro, Hôpital Bretonneau, CHRU Tours, 37044, Tours Cedex 1, France. emond@univ-tours.fr.; PST Analyse Des Systèmes Biologiques - Département d'Analyse Chimique Et Métabolomique - METABOHUB, Université de Tours, Tours, France. emond@univ-tours.fr.
Publikováno v: EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Aug 27; Vol. 9 (1), pp. 63. Date of Electronic Publication: 2024 Aug 27.
Zobrazit plný text záznamu
2
Akademický článek
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Autor: Chauveau F; Université Claude Bernard Lyon 1, Centre de Recherche en Neurosciences de Lyon, Inserm U1028, CNRS UMR5292, BIORAN, Groupement Hospitalier Est - CERMEP, 59 boulevard Pinel, 69677, Bron, Cedex, France., Winkeler A; Université Paris-Saclay, Inserm, CNRS, CEA, BioMaps, Service Hospitalier Frédéric Joliot, 4 place du général Leclerc, 91401, Orsay, France., Chalon S; UMR 1253 iBrain, Université de Tours - INSERM, Bâtiment Planiol, UFR de Médecine, 10 Boulevard Tonnellé, 37032, Tours, Cedex 01, France., Boutin H; UMR 1253 iBrain, Université de Tours - INSERM, Bâtiment Planiol, UFR de Médecine, 10 Boulevard Tonnellé, 37032, Tours, Cedex 01, France. herve.boutin@inserm.fr., Becker G; Université Claude Bernard Lyon 1, Centre de Recherche en Neurosciences de Lyon, Inserm U1028, CNRS UMR5292, BIORAN, Groupement Hospitalier Est - CERMEP, 59 boulevard Pinel, 69677, Bron, Cedex, France.; Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, 14 rue Pierre et Marie Curie, 94701, Maisons-Alfort, Cedex, France.
Publikováno v: Molecular psychiatry [Mol Psychiatry] 2024 Jul 13. Date of Electronic Publication: 2024 Jul 13.
Zobrazit plný text záznamu
3
Akademický článek
Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum.
Autor: Barber BE; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia., Webster R; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Potter AJ; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Llewellyn S; QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Sahai N; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Leelasena I; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Mathison S; University of the Sunshine Coast Clinical Trials, Morayfield, QLD, Australia., Kuritz K; IntiQuan GmbH, Basel, Switzerland., Flynn J; Medicines for Malaria Venture, Geneva, Switzerland., Chalon S; Medicines for Malaria Venture, Geneva, Switzerland., Marrast AC; Medicines for Malaria Venture, Geneva, Switzerland., Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland., Moehrle JJ; Medicines for Malaria Venture, Geneva, Switzerland. Electronic address: moehrlej@mmv.org.
Publikováno v: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jul; Vol. 64 (1), pp. 107196. Date of Electronic Publication: 2024 May 10.
Zobrazit plný text záznamu
4
Akademický článek
Longitudinal changes in iron homeostasis in human experimental and clinical malaria.
Autor: Woolley SD; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, United Kingdom., Grigg MJ; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia., Marquart L; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; School of Public Health, University of Queensland, Brisbane, Australia., Gower JSE; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Piera K; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia., Nair AS; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Amante FM; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Rajahram GS; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Department of Medicine, Queen Elizabeth II Hospital, Kota Kinabalu, Malaysia; Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia., William T; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia; Subang Jaya Medical Centre, Subang Jaya, Malaysia., Frazer DM; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Chalon S; Medicines for Malaria Venture, Geneva, Switzerland., McCarthy JS; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Victorian Infectious Diseases Institute, Peter Doherty Institute, University of Melbourne, Melbourne, Australia., Anstey NM; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia., Barber BE; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia; Infectious Diseases Department, Royal Brisbane and Women's Hospital, Brisbane, Australia. Electronic address: bridget.barber@qimrberghofer.edu.au.
Publikováno v: EBioMedicine [EBioMedicine] 2024 Jul; Vol. 105, pp. 105189. Date of Electronic Publication: 2024 Jun 07.
Zobrazit plný text záznamu
5
Akademický článek
A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants.
Autor: Kuemmerle A; Medicines for Malaria Venture, ICC - Block G, 3rd floor, 20, Route de Pré-Bois, PO Box 1826, 1215, Geneva, Switzerland., Gossen D; Mangareva SRL, Kraainem, Belgium., Marx MW; ICON Clinical Research Germany GmbH, Langen, Germany., Lorch U; Richmond Pharmacology Ltd, London, UK., Szramowska M; PharmaKinetic Ltd, Quorn, UK., Kumar A; IPCA Laboratories Limited, Mumbai, India., Singh D; IPCA Laboratories Limited, Mumbai, India., Singh S; IPCA Laboratories Limited, Mumbai, India., Ramachandruni H; Medicines for Malaria Venture, ICC - Block G, 3rd floor, 20, Route de Pré-Bois, PO Box 1826, 1215, Geneva, Switzerland., Thankachen B; IPCA Laboratories Limited, Mumbai, India., Kore S; IPCA Laboratories Limited, Mumbai, India., Gaaloul ME; Medicines for Malaria Venture, ICC - Block G, 3rd floor, 20, Route de Pré-Bois, PO Box 1826, 1215, Geneva, Switzerland., Borghini-Fuhrer I; Medicines for Malaria Venture, ICC - Block G, 3rd floor, 20, Route de Pré-Bois, PO Box 1826, 1215, Geneva, Switzerland., Chalon S; Medicines for Malaria Venture, ICC - Block G, 3rd floor, 20, Route de Pré-Bois, PO Box 1826, 1215, Geneva, Switzerland. chalons@mmv.org.
Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.
Zobrazit plný text záznamu
6
Akademický článek
Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin.
Autor: Kuemmerle A; Medicines for Malaria Venture, Geneva, Switzerland., Gossen D; Mangareva SRL, Kraainem, Belgium., Janin A; AKJ Consulting, Divonne, France., Stokes A; Richmond Pharmacology Ltd., London, UK., Abla N; Medicines for Malaria Venture, Geneva, Switzerland., Szramowska M; PharmaKinetic Ltd., Quorn, UK., Lorch U; Richmond Pharmacology Ltd., London, UK., El Gaaloul M; Medicines for Malaria Venture, Geneva, Switzerland., Borghini-Fuhrer I; Medicines for Malaria Venture, Geneva, Switzerland., Chalon S; Medicines for Malaria Venture, Geneva, Switzerland.
Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13738.
Zobrazit plný text záznamu
7
Longitudinal changes in iron homeostasis in human experimental and clinical malaria.
Autor: Woolley SD; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, United Kingdom., Grigg MJ; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia., Marquart L; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; School of Public Health, University of Queensland, Brisbane, Australia., Gower J; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Piera K; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia., Nair AS; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Amante FM; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Rajahram GS; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia.; Department of Medicine, Queen Elizabeth II Hospital, Kota Kinabalu, Malaysia.; Clinical Research Centre, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia., William T; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia.; Department of Medicine, Queen Elizabeth II Hospital, Kota Kinabalu, Malaysia.; Subang Jaya Medical Centre, Subang Jaya, Malaysia., Frazer DM; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Chalon S; Medicines for Malaria Venture, Geneva, Switzerland., McCarthy JS; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Victorian Infectious Diseases Institute, Peter Doherty Institute, University of Melbourne, Melbourne, Australia., Anstey NM; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia., Barber BE; Infection and Inflammation Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.; Infectious Diseases Society Kota Kinabalu Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Malaysia.; Infectious Diseases Department, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Dec 21. Date of Electronic Publication: 2023 Dec 21.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje